Library / regulatory-reference
Bahrain: National Health Regulatory Authority (NHRA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Health Regulatory Authority, known as the NHRA, is Bahrain's independent regulator for health care, including medicines and medical products.
Bahrain imports nearly all of its medicines, and the authority's registration and licensing decisions govern a compact market serving a mixed public-private health system.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy documentation, and establishments and health professionals are licensed and inspected by the authority.
Post-market work includes safety monitoring and recalls, with the authority's remit spanning products, facilities and practitioners in one body.
Regional and international role
Bahrain participates in Gulf regulatory cooperation, aligning requirements with neighboring states and their joint purchasing program.
Its single-authority model, covering products, facilities and professionals, is a distinctive structure among small Gulf states.
Using this profile
The authority publishes regulations and announcements in English and Arabic through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Bahrain illustrates the all-in-one health regulator: products, providers and professionals under one independent authority.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.